Related Experiment Video

Updated: Jul 5, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

Proteomics in atherosclerosis

Roxana Martinez-Pinna1, Jose Luis Martin-Ventura, Sebastian Mas

  • 1Vascular Research Laboratory, Fundación Jiménez Díaz, Avenida Reyes Católicos 2, 28040, Madrid, Spain.

Current Atherosclerosis Reports
|May 21, 2008
PubMed

Insights

Atherothrombosis, a major cause of death, involves vascular proteins. Proteomics offers new ways to find biological markers for cardiovascular risk.

Area of Science:

  • Cardiovascular Research
  • Proteomics
  • Biomarker Discovery

Background:

  • Atherothrombosis underlies major causes of death like heart attacks and strokes.
  • Vascular cell and plaque proteins in plasma are modified during atherothrombosis.
  • These proteins are key targets for identifying novel cardiovascular risk biomarkers.

Purpose of the Study:

  • To review proteomic techniques for cardiovascular research.
  • To summarize recent findings using high-throughput proteomics on cardiovascular samples.
  • To highlight the potential of proteomics in discovering cardiovascular risk markers.

Main Methods:

  • Review of proteomic techniques.
  • Analysis of high-throughput proteomic data from cardiovascular samples.
  • Literature search for recent advancements in the field.

Main Results:

  • Proteomic strategies have been applied to cardiovascular samples.
  • Recent studies have identified potential protein biomarkers.
  • High-throughput proteomics shows promise for cardiovascular risk assessment.

Conclusions:

  • Proteomics is a valuable tool in understanding atherothrombosis.
  • Further research can identify novel protein biomarkers for cardiovascular risk.
  • Proteomic insights can advance the diagnosis and management of cardiovascular diseases.

More Related Videos

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...